Background The standard of care for neovascular age-related macular degeneration (nAMD) is repeated intravitreal injection ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ...

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...

Key findings from the DME AWARE initiative highlight the importance of non-invasive treatment options for early intervention ...

Enrollment underway in SOL-X long-term extension trial in wet AMD for subjects completing two-year follow-up in SOL-1 or ...

Adding vamikibart to VEGF inhibition improved visual acuity and retinal anatomy ...

Published results showed patients who received a higher number of corticosteroid injections before total shoulder ...

A new investigation from ProPublica has people once again talking about vitamin K shots for newborns. Here's what to know.

It’s tough to avoid the current hype about the health benefits of injecting peptides. Although these substances – essentially ...